Collegium Pharma (COLL) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Collegium Pharma (COLL) Misses Q3 EPS by 3c

Collegium Reports Third Quarter 2019 Financial Results

November 6, 2019 4:01 PM EST

New Exclusive Formulary Wins Announced for Xtampza® ER Effective January 1, 2020 Covering More than 35 Million Lives

Xtampza® ER Net Product Revenues Were $26.5 Million in the Third Quarter of 2019, a 56% Increase Over the Third Quarter of 2018

Cash Increased by $5.1 Million, to $153.8 Million as of September 30, 2019

Conference Call Scheduled for Today at 4:30 p.m. ET

STOUGHTON, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) --... More